| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/06/2008 | WO2008034123A3 Polymeric conjugates containing positively-charged moieties |
| 11/06/2008 | WO2008030803A3 Hiv inhibitors |
| 11/06/2008 | WO2008021960A3 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 11/06/2008 | WO2008021896A3 Therapeutic methods for neuropathic pain |
| 11/06/2008 | WO2008021552A3 Biased ligands and methods of identifying same |
| 11/06/2008 | WO2008014431A3 Method of treating ocular infections |
| 11/06/2008 | WO2008011120A3 Human endogenous retrovirus polypeptide compositions and methods of use thereof |
| 11/06/2008 | WO2008005506A3 An ebv inhibitor and methods of making and using the same |
| 11/06/2008 | WO2007145987A8 J-superfamily conotoxin peptides |
| 11/06/2008 | WO2007138382A3 Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| 11/06/2008 | WO2007136819A3 Use of peptides containing a cholesterol interaction sequence for treating hypercholesterolemia, viral infection, obesity and diabetes |
| 11/06/2008 | WO2007120673A3 Immunogenic wt-1 peptides and methods of use thereof |
| 11/06/2008 | WO2007112024A3 Barbed sutures having a therapeutics agent thereon |
| 11/06/2008 | WO2007101063A3 Treatment of development-related disorders |
| 11/06/2008 | WO2007100718A3 Neurotensin receptor agonists and opioid receptor agonists |
| 11/06/2008 | WO2007100580A3 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 11/06/2008 | WO2007089601A3 Nogo receptor antagonists |
| 11/06/2008 | WO2007082154A3 B7-h1 and b7-h4 in cancer |
| 11/06/2008 | WO2007075388A3 Methods of locally treating and preventing cardiac disorders |
| 11/06/2008 | WO2006071840A3 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 11/06/2008 | WO2006028645B1 Method for remodeling bone and related sutures |
| 11/06/2008 | US20080276327 Using insect models as tools in screening for modulators of neurodegenerative and psychological disorders |
| 11/06/2008 | US20080275218 Ly6h gene |
| 11/06/2008 | US20080275217 Filamin A interacting protein 1 for use in directed destruction of actin binding protein filamin-1; treating neurodegenerative disorders |
| 11/06/2008 | US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 11/06/2008 | US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide |
| 11/06/2008 | US20080275017 Aromatic sulfenates for type i phototherapy |
| 11/06/2008 | US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 11/06/2008 | US20080274996 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin |
| 11/06/2008 | US20080274995 Suppression of Nuclear Factor-KappaB Dependent Processes Using Oligonucleotides |
| 11/06/2008 | US20080274994 Dna sequence and genomic structure of human cardiac isoform; gene or allele mutants associated with cardiovascular disorders; reduce stretch activation and adjust tension of muscles in heart contraction; isolated nucleic acid encoding a protein |
| 11/06/2008 | US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
| 11/06/2008 | US20080274982 Peptide Substance Restoring Respiratory Organs Function |
| 11/06/2008 | US20080274981 Compositions and methods for regulating apoptosis |
| 11/06/2008 | US20080274980 Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation |
| 11/06/2008 | US20080274979 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 11/06/2008 | US20080274978 Tryptophan rich mimics; antiinflammatory agents; drug screening for formyl peptide receptor like 1 (FPRL1) activity; arthritis, autoimmune disorders, Alzheimer's disease |
| 11/06/2008 | US20080274977 Treating stroke and other diseases without inhibiting N-type calcium channels |
| 11/06/2008 | US20080274976 Uses of novel potassium channel blockers |
| 11/06/2008 | US20080274975 Human A beta binding alcohol dehydrogenase (ABAD) inhibitors; amino acid sequence 94-114 of ABAD; Alzheimer's disease; reducing free radical generation, DNA fragmentation and cytochrome C cellular release; preserving cell viability |
| 11/06/2008 | US20080274974 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 11/06/2008 | US20080274973 Isolated polypeptides comprising sequence 4 fragments; agonists, antagonists, diagnostic reagents |
| 11/06/2008 | US20080274972 T-cell epitope peptides |
| 11/06/2008 | US20080274971 Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation |
| 11/06/2008 | US20080274970 Vascular adhesion molecules and modulation of their function |
| 11/06/2008 | US20080274969 Albumin-Fused Kunitz Domain Peptides |
| 11/06/2008 | US20080274968 In vitro methods for detecting renal cancer |
| 11/06/2008 | US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof |
| 11/06/2008 | US20080274966 Biglycan and related therapeutics and methods of use |
| 11/06/2008 | US20080274965 Encapsulated amyloid-beta peptides |
| 11/06/2008 | US20080274964 Human Spasmolytic Polypeptide in Glycosylated Form |
| 11/06/2008 | US20080274963 Modulation of Granulosa Cell Apoptosis |
| 11/06/2008 | US20080274962 Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis |
| 11/06/2008 | US20080274961 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activated peptide |
| 11/06/2008 | US20080274960 Fibrosis Inhibitor for Implanted Organ |
| 11/06/2008 | US20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster |
| 11/06/2008 | US20080274958 Glycosylation of peptides via o-linked glycosylation sequences |
| 11/06/2008 | US20080274957 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 11/06/2008 | US20080274956 Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein |
| 11/06/2008 | US20080274955 Prevent migration,adhesion, proliferation of endiothelial cells; angiogenesis inhibition; induction apoptosis; anticancer agents; vascular disorders; artheriosclerosis; vision disorders; retinopathy; antiarthritic agents;lupus; skin disorders |
| 11/06/2008 | US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer |
| 11/06/2008 | US20080274953 Method of Preparing a Protein Aggregate and a Pharmaceutical Preparation |
| 11/06/2008 | US20080274952 Therapy for metabolism disorders; obesity; diabetes; cardovascular disordrs; eating disorders; hypoglycemic agents; hypotensive agents; dyslipidemia; sleep disorders; respiraotry system disorders; osteoarthritis; insulin resistance |
| 11/06/2008 | US20080274951 Pharmaceutical compositions including low dosages of desmopressin |
| 11/06/2008 | US20080274950 Intensify binding between cadherin molecules by reducing intramolecular binding within the cadherin molecules; reduce ionic bonding |
| 11/06/2008 | US20080274949 Formulation of Albumin-Free Erythropoietin |
| 11/06/2008 | US20080274947 Antilipemic agents; metabolic disorders; insulin resistance; antidiabetic agents |
| 11/06/2008 | US20080274946 Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
| 11/06/2008 | US20080274945 Infant Nutrition With Protease Inhibitor |
| 11/06/2008 | US20080274549 System and Method For Electroporating a Sample |
| 11/06/2008 | US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells |
| 11/06/2008 | US20080274505 Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof |
| 11/06/2008 | US20080274504 Expression vector comprising nucleotide sequences coding human estrogen receptor for use as negative regulator of heregulin and treatment for prostatic and breast cancers |
| 11/06/2008 | US20080274498 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides |
| 11/06/2008 | US20080274472 Novel kinases and uses thereof |
| 11/06/2008 | US20080274468 Novel means for the diagnosis and therapy of ctcl |
| 11/06/2008 | US20080274195 Compositions and Methods for Making and Using Nanoemulsions |
| 11/06/2008 | US20080274190 Comprising a poly(ethylene glycol)-based compound, or a copolymer of the poly(ethylene glycol)-based compound and a biodegradable polymer; and a polyurethane-based oligomer |
| 11/06/2008 | US20080274186 NELL-1 enhanced bone mineralization |
| 11/06/2008 | US20080274183 Melt extrudable, polymeric fiber suitable for controlled, sustained internal administration; blend of cellulose alkyl ester and secondary biocompatible polymer |
| 11/06/2008 | US20080274176 Pharmaceutical Lipid Compositions |
| 11/06/2008 | US20080274170 Peptide epitopes of apolipoprotein b |
| 11/06/2008 | US20080274165 Wound healing compositions containing keratin biomaterials |
| 11/06/2008 | US20080274158 biodegradable hydrogel FGF-beta mimetic; PEG-dihydrazide crosslinking agent for a desamino-tyrosyl-tyrosine dipeptide or polypeptides thereof; implantable resorbable medical device; wound healing; the water soluble polymer can also be polysaccharide, polyvinyl alcohol or poly(N-methyl pyrrolidone) |
| 11/06/2008 | US20080274155 Chimeric Cannulae Proteins, Nucleic Acids Encoding Them And Methods For Making And Using Them |
| 11/06/2008 | US20080274149 Encapsulation and Controlled Release of Biologically Active Ingredients with Enzymatically Degradable Microparticulate, Hyperbranched Polymers |
| 11/06/2008 | US20080274143 Chloroplasts Engineering to Express Pharmaceutical Proteins |
| 11/06/2008 | US20080274132 Vaccines for blocking transmission of plasmodium vivax |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274130 Rabies Virus Vector Systems and Compositions and Methods Thereof |
| 11/06/2008 | US20080274129 Hla-A2 Tumor Associated Antigen Peptides and Compositions |
| 11/06/2008 | US20080274128 Heat shock protein-based vaccines and immunotherapies |
| 11/06/2008 | US20080274127 Using probiotic nutrient mix comprising synthetic peptides, free amino acids and/or protein hydrolysates as therapeutic in treatment of gastrointestinal distress and to enhance immune system response |
| 11/06/2008 | US20080274117 Using monoclonal antibody specific to testis-specific serine kinase (TSSK) as tool in controlling reproduction |
| 11/06/2008 | US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders |
| 11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/06/2008 | US20080274098 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to a Neuro-, Muscular- or Neuro-Muscular-Degenerative Disease, or Restore Tissue Adversely Affected by Said Disease |
| 11/06/2008 | US20080274097 Using ultrasonic vibration at treatment sites to enhance efficacy of therapeutic treatment |
| 11/06/2008 | US20080274096 Fusion Proteins Having a Modulated Half-Life in Plasma |